Endosense raised €31M in a Series C round in Nov 2012. The company is based in Geneva, Switzerland. Investors in the round: GIMV, Ysios Capital. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
